Skip Nav Destination
Issues
1 February 2003
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
Editorial
Minireview
The Biology Behind
Advances in Brief
Clinical Trials
Reduction of Wound Angiogenesis in Patients Treated with BMS-275291, a Broad Spectrum Matrix Metalloproteinase Inhibitor1
A. Craig Lockhart; Rod D. Braun; Daohai Yu; Joel R. Ross; Mark W. Dewhirst; Jeffrey S. Humphrey; Seth Thompson; Kathleen M. Williams; Bruce Klitzman; Fan Yuan; James M. Grichnik; Alan D. Proia; Delina A. Conway; Herbert I. Hurwitz
Clinical Trial
Immunoscintigraphic Detection of the ED-B Domain of Fibronectin, a Marker of Angiogenesis, in Patients with Cancer1
Monica Santimaria; Giovanni Moscatelli; Giuseppe L. Viale; Leonardo Giovannoni; Giovanni Neri; Francesca Viti; Alessandra Leprini; Laura Borsi; Patrizia Castellani; Luciano Zardi; Dario Neri; Pietro Riva
Molecular Oncology, Markers, Clinical Correlates
High and Differential Expression of HER-2/neu Extracellular Domain in Bilateral Ductal Fluids from Women with Unilateral Invasive Breast Cancer1
Henry M. Kuerer; Patricia A. Thompson; Savitri Krishnamurthy; Herbert A. Fritsche; Sylvie M. Marcy; Gildy V. Babiera; S. Eva Singletary; Massimo Cristofanilli; Nour Sneige; Kelly K. Hunt
Experimental Therapeutics, Preclinical Pharmacology
Regular Articles
Clinical Trials
α1 Acid Glycoprotein Binds to Imatinib (STI571) and Substantially Alters Its Pharmacokinetics in Chronic Myeloid Leukemia Patients1
Carlo Gambacorti-Passerini; Massimo Zucchetti; Domenico Russo; Roberta Frapolli; Magda Verga; Silvia Bungaro; Lucia Tornaghi; Fabio Rossi; Pietro Pioltelli; Enrico Pogliani; Daniele Alberti; Gianmarco Corneo; Maurizio D’Incalci
Phase I Evaluation of Prolonged-infusion Gemcitabine with Fludarabine for Relapsed or Refractory Acute Myelogenous Leukemia1
David A. Rizzieri; Valerie K. Ibom; Joseph O. Moore; Carlos M. DeCastro; Gary L. Rosner; David J. Adams; Traci Foster; Nancy Payne; Maria Thompson; James J. Vredenburgh; Christina Gasparetto; Gwynn D. Long; Nelson J. Chao; Jon P. Gockerman
Activation of Human Melanoma Reactive CD8+ T Cells by Vaccination with an Immunogenic Peptide Analog Derived from Melan-A/Melanoma Antigen Recognized by T Cells-11
Maha Ayyoub; Alfred Zippelius; Mikaël J. Pittet; Donata Rimoldi; Danila Valmori; Jean-Charles Cerottini; Pedro Romero; Ferdy Lejeune; Danielle Liénard; Daniel E. Speiser
Mechanisms of Peritoneal Metastasis after Operation for Non-Serosa-invasive Gastric Carcinoma: An Ultrarapid Detection System for Intraperitoneal Free Cancer Cells and a Prophylactic Strategy for Peritoneal Metastasis
Takashi Marutsuka; Shinya Shimada; Kenji Shiomori; Naoko Hayashi; Yasushi Yagi; Takaaki Yamane; Michio Ogawa
Weekly Docetaxel as Neoadjuvant Chemotherapy for Stage II and III Breast Cancer: Efficacy and Correlation with Biological Markers in a Phase II, Multicenter Study1
Laura G. Estévez; José Miguel Cuevas; Antonio Antón; Jesús Florián; José Manuel López-Vega; Amalia Velasco; Francisco Lobo; Ana Herrero; José Fortes
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Combination of Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Gene Expressions in Primary Tumors as Predictive Parameters for the Efficacy of Fluoropyrimidine-based Chemotherapy for Metastatic Colorectal Cancer
Wataru Ichikawa; Hiroyuki Uetake; Yoshinori Shirota; Hiroyuki Yamada; Naoto Nishi; Zenro Nihei; Kenichi Sugihara; Renzo Hirayama
Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma: Implications for Prognosis and Therapy
Matthew H. T. Bui; David Seligson; Ken-ryu Han; Allan J. Pantuck; Frederick J. Dorey; Yunda Huang; Steve Horvath; Bradley C. Leibovich; Shefali Chopra; Shu-Yuan Liao; Eric Stanbridge; Michael I. Lerman; Aarno Palotie; Robert A. Figlin; Arie S. Belldegrun
Real-Time Analysis of Tyrosine Hydroxylase Gene Expression: A Sensitive and Semiquantitative Marker for Minimal Residual Disease Detection of Neuroblastoma1
Lambert H. J. Lambooy; Corrie E. M. Gidding; Lambert P. van den Heuvel; Christina A. Hulsbergen-van de Kaa; Marjolijn Ligtenberg; Jos P. M. Bökkerink; Ronney A. De Abreu
RNA Expression of Breast Cancer Resistance Protein, Lung Resistance-related Protein, Multidrug Resistance-associated Proteins 1 and 2, and Multidrug Resistance Gene 1 in Breast Cancer: Correlation with Chemotherapeutic Response
Herman Burger; John A. Foekens; Maxime P. Look; Marion E. Meijer-van Gelder; Jan G. M. Klijn; Erik A. C. Wiemer; Gerrit Stoter; Kees Nooter
Sequence Alterations in the Reduced Folate Carrier Are Observed in Osteosarcoma Tumor Samples1
Rui Yang; Rebecca Sowers; BethAnne Mazza; John H. Healey; Andrew Huvos; Holcombe Grier; Mark Bernstein; G. Peter Beardsley; Mark D. Krailo; Meenakshi Devidas; Joseph R. Bertino; Paul A. Meyers; Richard Gorlick
Establishment and Characterization of Cancer Cell Cultures and Xenografts Derived from Primary or Metastatic Mullerian Cancers1
Claire F. Verschraegen; Wei Hu; Yu Du; John Mendoza; Janet Early; Michael Deavers; Ralph S. Freedman; Robert C. Bast, Jr.; Andrzej P. Kudelka; John J. Kavanagh; Beppino C. Giovanella
Experimental Therapeutics, Preclinical Pharmacology
Combined Targeted Inhibition of bcl-2, bcl-XL, Epidermal Growth Factor Receptor, and Protein Kinase A Type I Causes Potent Antitumor, Apoptotic, and Antiangiogenic Activity
Giampaolo Tortora; Rosa Caputo; Vincenzo Damiano; Roberta Caputo; Teresa Troiani; Bianca Maria Veneziani; Sabino De Placido; Angelo Raffaele Bianco; Uwe Zangemeister-Wittke; Fortunato Ciardiello
Clinical Evaluation of Mitoxantrone and Piroxicam in a Canine Model of Human Invasive Urinary Bladder Carcinoma1
Carolyn J. Henry; Dudley L. McCaw; Susan E. Turnquist; Jeff W. Tyler; Lina Bravo; Sarah Sheafor; Rodney C. Straw; William S. Dernell; Bruce R. Madewell; Linda Jorgensen; Michael A. Scott; Mary Lynn Higginbotham; Ruthanne Chun
Letters to the Editor
Correction
Advertisement
